- /
- Supported exchanges
- / US
- / BBNX.NASDAQ
Beta Bionics, Inc. Common Stock (BBNX NASDAQ) stock market data APIs
Beta Bionics, Inc. Common Stock Financial Data Overview
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Beta Bionics, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Beta Bionics, Inc. Common Stock data using free add-ons & libraries
Get Beta Bionics, Inc. Common Stock Fundamental Data
Beta Bionics, Inc. Common Stock Fundamental data includes:
- Net Revenue: 110 M
- EBITDA: -75 455 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Beta Bionics, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-05-12
- EPS/Forecast: -0.33
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Beta Bionics, Inc. Common Stock News
New
Beta Bionics, Inc. Q1 2026 Earnings Call Summary
Beta Bionics, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Performance Drivers Revenue growth of 57% year-over-year was primarily driven by new patient starts and high retention within the gr...
Beta Bionics Q1 Sales Jump 57%; Lifts FY'26 Revenue Outlook
(RTTNews) - Beta Bionics Inc. (BBNX), a commercial-stage medical device company, released on Tuesday the financial results and business highlights of the first quarter of 2026, and raised the financia...
Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5%
Earnings Call Insights: Beta Bionics (BBNX) Q1 2026 MANAGEMENT VIEW * "We're pleased to share with you all today our financial results for the first quarter as well as positive updates to our full...
Beta Bionics Q1 Earnings Call Highlights
Beta Bionics logo Key Points Beta Bionics reported Q1 net sales of $27.6 million, up 57% year-over-year, driven by new patient starts and a rising base of recurring pharmacy users, and raised its fu...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.